BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19172510)

  • 1. Published international classification of retinoblastoma (ICRB) definitions contain inconsistencies--an analysis of impact.
    Novetsky DE; Abramson DH; Kim JW; Dunkel IJ
    Ophthalmic Genet; 2009 Mar; 30(1):40-4. PubMed ID: 19172510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The International Classification of Retinoblastoma predicts chemoreduction success.
    Shields CL; Mashayekhi A; Au AK; Czyz C; Leahey A; Meadows AT; Shields JA
    Ophthalmology; 2006 Dec; 113(12):2276-80. PubMed ID: 16996605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-risk retinoblastoma based on international classification of retinoblastoma: analysis of 519 enucleated eyes.
    Kaliki S; Shields CL; Rojanaporn D; Al-Dahmash S; McLaughlin JP; Shields JA; Eagle RC
    Ophthalmology; 2013 May; 120(5):997-1003. PubMed ID: 23399379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.
    Shields CL; Manjandavida FP; Lally SE; Pieretti G; Arepalli SA; Caywood EH; Jabbour P; Shields JA
    Ophthalmology; 2014 Jul; 121(7):1453-60. PubMed ID: 24656794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
    Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA
    Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoblastoma in Iran: outcomes in terms of patients' survival and globe survival.
    Naseripour M; Nazari H; Bakhtiari P; Modarres-zadeh M; Vosough P; Ausari M
    Br J Ophthalmol; 2009 Jan; 93(1):28-32. PubMed ID: 18952647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma.
    Abramson DH; Fabius AW; Francis JH; Marr BP; Dunkel IJ; Brodie SE; Escuder A; Gobin YP
    Ophthalmic Genet; 2017; 38(1):16-21. PubMed ID: 28095092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the best treatment for retinoblastoma?
    Harbour JW
    Am J Ophthalmol; 2004 Sep; 138(3):471-3. PubMed ID: 15364232
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
    Am J Ophthalmol; 2004 Sep; 138(3):329-37. PubMed ID: 15364213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma.
    Abramson DH; Frank CM; Dunkel IJ
    Ophthalmology; 1999 Oct; 106(10):1947-50. PubMed ID: 10519590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PREDICTIVE VALUE OF TNM CLASSIFICATION, INTERNATIONAL CLASSIFICATION, AND REESE-ELLSWORTH STAGING OF RETINOBLASTOMA FOR THE LIKELIHOOD OF HIGH-RISK PATHOLOGIC FEATURES.
    Yousef YA; Al-Hussaini M; Mehyar M; Sultan I; Jaradat I; AlRawashdeh K; Khurma S; Deebajah R; Nawaiseh I
    Retina; 2015 Sep; 35(9):1883-9. PubMed ID: 25923953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New retinoblastoma tumor formation in children initially treated with systemic carboplatin.
    Lee TC; Hayashi NI; Dunkel IJ; Beaverson K; Novetsky D; Abramson DH
    Ophthalmology; 2003 Oct; 110(10):1989-94; discussion 1994-5. PubMed ID: 14522776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic understanding of current classification and management of retinoblastoma.
    Shields CL; Shields JA
    Curr Opin Ophthalmol; 2006 Jun; 17(3):228-34. PubMed ID: 16794434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival with retinoblastoma in the USA: 1975-2004.
    Broaddus E; Topham A; Singh AD
    Br J Ophthalmol; 2009 Jan; 93(1):24-7. PubMed ID: 18718969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intraarterial chemotherapy on retinoblastoma-induced retinal detachment.
    Shields CL; Kaliki S; Shah SU; Bianciotto CG; Jabbour P; Shields JA
    Retina; 2012 Apr; 32(4):799-804. PubMed ID: 22105496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical manifestations and treatment of retinoblastoma in Korea.
    Chung SE; Sa HS; Koo HH; Yoo KH; Sung KW; Ham DI
    Br J Ophthalmol; 2008 Sep; 92(9):1180-4. PubMed ID: 18650212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The success of primary chemotherapy for group D heritable retinoblastoma.
    Cohen VM; Kingston J; Hungerford JL
    Br J Ophthalmol; 2009 Jul; 93(7):887-90. PubMed ID: 18703556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical presentation and group classification of newly diagnosed intraocular retinoblastoma in China.
    Zhao J; Li S; Shi J; Wang N
    Br J Ophthalmol; 2011 Oct; 95(10):1372-5. PubMed ID: 21252083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-Arterial Chemotherapy as Primary Therapy for Retinoblastoma in Infants Less than 3 Months of Age: A Series of 10 Case-Studies.
    Chen M; Zhao J; Xia J; Liu Z; Jiang H; Shen G; Li H; Jiang Y; Zhang J
    PLoS One; 2016; 11(8):e0160873. PubMed ID: 27504917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraocular retinoblastoma: the case for a new group classification.
    Linn Murphree A
    Ophthalmol Clin North Am; 2005 Mar; 18(1):41-53, viii. PubMed ID: 15763190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.